|
Real-time Estimate
Cboe BZX
07:10:57 13/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1.100 USD | 0.00% |
|
-3.51% | -34.13% |
| 07/08 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 07/08 | Lineage Cell Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
Stock exchange
NYSE
LCTX 1.100 $
-1.79%
8L
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NYSE
| LCTX | 1.100USD | -1.79% | 8L $ | |
CBOE
| LCTX | 1.090USD | -2.24% | 22.08T $ | |
|
TEL AVIV STOCK EXCHANGE
| LCTX | 343.90ILa | +3.46% | 8L ILa | |
|
Tradegate
| BT3 | 0.9510EUR | -1.55% | 71.32 € | |
|
Boerse Muenchen
| BT3 | 0.9360EUR | -3.60% | 0.94 € | |
|
Deutsche Boerse AG
| BT3 | 0.9260EUR | -1.49% | 0 € | |
|
Börse Stuttgart
| BT3 | 0.9330EUR | 0.00% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.2 | 1.35 | 1.35 |
| Spread/Res. | -8.33% | -18.52% | -18.52% |
| Spread/Supp. | +6.80% | +6.80% | +6.80% |
| Support | 1.03 | 1.03 | 1.03 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
